[Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin]. [electronic resource]
Producer: 20040520Description: 35-40 p. digitalISSN:- 0004-0614
- Aged
- Aged, 80 and over
- Anemia -- drug therapy
- Antineoplastic Agents -- therapeutic use
- Epoetin Alfa
- Erythropoietin -- adverse effects
- Hematinics -- adverse effects
- Hemoglobins -- analysis
- Humans
- Male
- Middle Aged
- Prospective Studies
- Prostatic Neoplasms -- drug therapy
- Quality of Life
- Recombinant Proteins
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.